Sign up to save your podcasts
Or
Share Having Productive Conversations with Patients at High Risk for HIV
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Having Productive Conversations with Patients at High Risk for HIV
CME credits: 0.25
Valid until: 31-03-2023
Claim your CME credit at https://reachmd.com/programs/cme/having-productive-conversations-with-patients-at-high-risk-for-hiv/13304/
The CDC’s 2021 update to their PrEP guidelines recommend that PrEP should be offered to all individuals who want or need it. Although PrEP is both safe and extremely effective, persistence to PrEP in the long-term is low, at about 40% at 2 years. Join Drs. Wohl and Hightow-Weidman as they discuss the challenges associated with increasing PrEP uptake and how the emergence of a long-acting injectable PrEP formulation could result in improved long-term persistence.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 31-03-2023
Claim your CME credit at https://reachmd.com/programs/cme/having-productive-conversations-with-patients-at-high-risk-for-hiv/13304/
The CDC’s 2021 update to their PrEP guidelines recommend that PrEP should be offered to all individuals who want or need it. Although PrEP is both safe and extremely effective, persistence to PrEP in the long-term is low, at about 40% at 2 years. Join Drs. Wohl and Hightow-Weidman as they discuss the challenges associated with increasing PrEP uptake and how the emergence of a long-acting injectable PrEP formulation could result in improved long-term persistence.
=